Role of lipids in chronic renal allograft rejection

Contributions to Nephrology

Volumn 120, Issue , 1997, Pages 62-67

  Swan, Suzanne K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALLOTRANSPLANTATION; BLOOD; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; REVIEW;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; GRAFT REJECTION; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIPIDS; TRANSPLANTATION, HOMOLOGOUS; TRIGLYCERIDES;

EID: 0030624593     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059824     Document Type: Article

References (34)

1. Paul LC: Chronic renal transplant loss. Kidney Int 1995;47:1491-1499.
2. Dunn J, Golden D, VanBuren CT, Lewis RM, Lawen J, Kahan B: Causes of graft loss beyond two years in the cyclosporine era. Transplantation 1990;49:349-353.
3. Hostetter TH: Chronic transplant rejection. Kidney Int 1994;46:266-279.
4. Bia MJ: Nonimmunologic causes of late renal graft loss. Kidney Int 1995;47:1470-1480.
5. Häyry P, Isoniemi H, Yilmaz S, Mennander A, Lemstrom K, Raisanen-Sokolowski A, Koskinen P, Ustinov J, Lautenschlager I, Taskinen E, Krogerus L, Aho P, Paavonen T: Chronic allograft rejection. Immunol Rev 1993;134:33-81.
6. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH: Chronic rejection - An undefined conundrum. Transplantation 1991;52:389-398.
7. Kasiske BL, Kalil RSN, Lee HS, Rao KV: Histopathologic findings associated with a chronic progressive decline in renal allograft function. Kidney Int 1991;40:514-524.
8. Vollmer E, Bosse A, Bogeholz J, Roessner A, Blasius S, Fahrenkamp A, Boker W, Sorg C: Apolipoproteins and immunohistological differentiation of cells in the arterial wall of kidneys in transplant arteriopathy: Morphological parallels with atherosclerosis. Pathol Res Pract 1991;187:957-962.
9. Alonso DR, Starek PK, Minick CR: Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol 1977;87:415-442.
10. Tsaltas TT, Friedman EA: Plasma lipid studies of uremic patients during hemodialysis. Am J Clin Nutr 1968;21:430-435.
11. Lamberth EL, Oates JA: Plasma lipid patterns in chronic renal failure. Trans Am Soc Artif Intern Organs 1975;21:473-478.
12. Bagdade JD, Porte D, Bierman EL: Hypertriglyceridemia: A metabolic consequence of chronic renal failure. N Engl J Med 1968;279:181-185.
13. Casaretto A, Marchioro T, Bagdade JD: Hyperlipidemia following renal transplantation. Trans Am Soc Artif Intern Organs 1973;19:11.
14. Markell MS, Armenti V, Danovitch G, Sumrani N: Hyperlipidemia and glucose intolerance in the post-renal transplant patient. J Am Soc Nephrol 1994;4:S37-S47.
15. Guijarro C, Massy ZA, Kasiske BL: Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int 1995;48:S56-S59.
16. Divakar D, Bailey RR, Frampton CM, George PM, Walmsley TA, Murphy J: Hyperlipidemia in stable renal transplant recipients. Nephron 1991;59:423-428.
17. Charlesworth JA, Edwards KDG: Relation of hypertriglyceridemia to kidney transplant dysfunction and rejection, and response to antilymphocyte globulin therapy. Drugs Kidney 1974;9:107-120.
18. Cattran DC, Steiner G, Wilson DR, Fenton SSA: Hyperlipidemia after renal transplantation - Natural history and pathophysiology. Ann Intern Med 1979;91:554-559.
19. Dimény E, Tufveson G, Lithell H, Larsson E, Siegbahn A, Fellström B: The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation. Eur J Clin Invest 1993;23:572-579.
20. Solez K, Axelson RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani K, von Willebrand E, Yanaguchi Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411-422.
21. Kasiske BL, Lee HS, Kim Y, O'Donnell MP, Keane WF: Independent effects of cholesterol and HMG-CoA reductase inhibition on chronic vascular rejection in rats (abstract). J Am Soc Nephrol 1992;3:843.
22. Fellström B, Dimény E, Larsson E, Claesson K, Tufveson G: Rapidly proliferative arteriopathy in cyclosporin-induced permanently surviving rat cardiac allografts simulating chronic vascular rejection. Clin Exp Immunol 1990;80:288-292.
23. Apanay DC, Neylan JF, Ragab MS, Sgoutas DS: Cyclosporin increases the oxidazability of low-density lipoproteins in renal transplant recipients. Transplantation 1994;58:663-669.
24. Steinberg D, Parthasarathy S, Carew TE, Khoo JL, Witztum JL: Beyond cholesterol modifications of LDL that increase its atherogenicity. N Engl J Med 1989;320:916-924.
25. Ghanem H, van den Dorpel MA, Weimar W, Man in't Veld AJ, El-kannishy MH, Jansen H: Increased low density lipoprotein oxidation in stable kidney transplant recipients. Kidney Int 1996;49:488-493.
26. Fellström BC, Larsson E, Pathogenesis and treatment perspectives of chronic graft rejection (CVR). Immunol Rev 1993;134:83-98.
27. Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J: Induction of T cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992;12:461.
28. Fellström B, Larsson E, Claesson K, Tufveson G, Wahlberg J, Klareskog L: Macrophages and T-lymphocytes expressing HLA-D region encoded gene products in rejected renal transplants. Transplant Proc 1988;20:372.
29. Moorhead JF: Lipids and progressive kidney disease. Kidney Int 1991;39:S35-S40.
30. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 1991;39:S41-S48.
31. Gao SZ, Schroeder JS, Alderman EL, Hunt SH, Silverman JF, Weiderhold V, Stinson EB: Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation 1987;76:V56-V61.
32. Dimény E, Fellström B, Larsson E, Tufveson G, Lithell H: Chronic vascular rejection and hyperlipoproteinemia in renal transplant patients. Clin Transplant 1993;7:482-490.
33. Isoniemi H, Nurminen M, Tikkanen MJ, von Willebrand E, Krogerus L, Ahonen J, Eklund B, Hockerstedt K, Salmela K, Häyry P: Risk factors predicting chronic rejection of renal allografts. Transplantation 1994;57:68-72.
34. Markell MS, Sumrani N, Dibenedetto A, Friedman EA: Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients. Am J Kidney Dis 1993;22:233-239.